Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.
2.

Effect of simvastatin and fenofibrate on cytokine release and systemic inflammation in type 2 diabetes mellitus with mixed dyslipidemia.

Krysiak R, Gdula-Dymek A, Okopien B.

Am J Cardiol. 2011 Apr 1;107(7):1010-1018.e1. doi: 10.1016/j.amjcard.2010.11.023. Epub 2011 Jan 26.

PMID:
21276586
3.

Fenofibrate: a review of its lipid-modifying effects in dyslipidemia and its vascular effects in type 2 diabetes mellitus.

Keating GM.

Am J Cardiovasc Drugs. 2011 Aug 1;11(4):227-47. doi: 10.2165/11207690-000000000-00000. Review.

PMID:
21675801
4.

"If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.

Tenenbaum A, Fisman EZ.

Cardiovasc Diabetol. 2010 Jun 15;9:24. doi: 10.1186/1475-2840-9-24.

5.

Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study).

May HT, Anderson JL, Pearson RR, Jensen JR, Horne BD, Lavasani F, Yannicelli HD, Muhlestein JB.

Am J Cardiol. 2008 Feb 15;101(4):486-9. doi: 10.1016/j.amjcard.2007.09.095. Epub 2007 Dec 26.

PMID:
18312763
7.

Rosiglitazone influences the expression of leukocyte adhesion molecules and CD14 receptor in type 2 diabetes mellitus patients.

Štulc T, Svobodová H, Krupičková Z, Doležalová R, Marinov I, Češka R.

Physiol Res. 2014;63 Suppl 2:S293-8.

8.

[Should the treatment of diabetic dyslipidemia be modified after the Action to Control Cardiovascular Risk in Diabetes Lipid study?].

Pérez A.

Endocrinol Nutr. 2010 Dec;57(10):457-9. doi: 10.1016/j.endonu.2010.05.010. Epub 2010 Aug 4. Spanish. No abstract available.

PMID:
20688585
9.

Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients.

Rezaie-Majd A, Prager GW, Bucek RA, Schernthaner GH, Maca T, Kress HG, Valent P, Binder BR, Minar E, Baghestanian M.

Arterioscler Thromb Vasc Biol. 2003 Mar 1;23(3):397-403. Epub 2003 Jan 30.

10.

Fenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemia.

Filippatos TD, Elisaf MS.

Expert Opin Pharmacother. 2011 Aug;12(12):1945-58. doi: 10.1517/14656566.2011.593509. Epub 2011 Jul 8. Review.

PMID:
21736529
11.
12.

Fenofibrate, simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patients.

Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, Palumbo I, D'Angelo A, Cicero AF.

Curr Med Res Opin. 2009 Aug;25(8):1973-83. doi: 10.1185/03007990903073159.

PMID:
19555253
13.

The effect of hypolipidemic treatment on monocyte cytokine release in different age groups of patients with type 2 diabetes and atherogenic dyslipidemia.

Krysiak R, Gdula-Dymek A, Marek B, Okopień B.

Endokrynol Pol. 2016;67(2):190-6. doi: 10.5603/EP.a2016.0021. Epub 2016 Feb 17.

14.

Effect of simvastatin and fenofibrate on endothelium in Type 2 diabetes.

Skrha J, Stulc T, Hilgertová J, Weiserová H, Kvasnicka J, Ceska R.

Eur J Pharmacol. 2004 Jun 16;493(1-3):183-9.

PMID:
15189781
15.

[Efficacy and safety of combination therapy with simvastatin and fenofibrate for combined hyperlipidemia].

Ren JY, Chen H, Luo Y.

Zhonghua Xin Xue Guan Bing Za Zhi. 2005 Feb;33(2):122-6. Chinese.

PMID:
15924805
16.
17.

Polymorphonuclear leukocyte integrin pattern, at baseline and after activation, in type 2 diabetic subjects with macrovascular complications.

Caimi G, Montana M, Ferrara F, Porretto F, Musso M, Canino B, Lo Presti R.

Acta Diabetol. 2003 Mar;40(1):14-9.

PMID:
12682824
18.

Summarizing the FIELD study: lessons from a 'negative' trial.

Tsimihodimos V, Mikhailidis DP, Elisaf M.

Expert Opin Pharmacother. 2013 Dec;14(18):2601-10. doi: 10.1517/14656566.2013.850075. Epub 2013 Nov 9. Review.

PMID:
24206060
20.

Time course of CD marker expression in patients with burns and its prognostic value.

Szelig L, Rendeki S, Foldi V, Lantos J, Bogar L, Csontos C.

Burns. 2014 Jun;40(4):575-82. doi: 10.1016/j.burns.2013.09.023. Epub 2013 Nov 19.

PMID:
24262512

Supplemental Content

Support Center